The CDC is pleased to announce the launch of CORIDOR, the National Center for Chronic Disease Prevention and Health Promotion’s (NCCDPHP) Collection of Online Resources & Inventory Database. CORIDOR is an organized and readily accessible source for public health practitioners to use in planning, implementation, and evaluation of state and national chronic disease prevention and health promotion initiatives. The resources included are primarily practice-based and represent science and practice promoted by CDC and CDC funded partners to address chronic disease conditions and risk factors. Tools include model policies and programs, guides, toolkits, and other resources for a variety of audiences with a range of skills.
Observing that “lifesaving technologies have proliferated dramatically within the past few decades, yet there is scant understanding of the ramifications of such technologies in the world of patients and their families,” PRC Researcher Frances Barg, PhD, MEd, and co-authors examine how patients and their families face health decisions that accompany use of the LVAD (left ventricular assist device) heart pump in the January 2017 issue of The American Journal of Bioethics.
“The findings from our study sound the call for further investigation of nuanced approaches to patient-centered interventions that take into account the impact of technologies on meaning, identity, and patient and family experience,” according to the authors. “Such intervention may better prepare and orient patients and their families to life with the LVAD. It is incumbent upon those of us who work with these technologies to recognize the complexities of these experiences and reflect upon the emergent ethical, clinical, and social cultures that can obscure them.”
UPenn PRC’s Chyke Doubeni (pictured) recommends assessing risk and change over time when determining colorectal cancer screening guidelines.
In a recent editorial in the journal Gastroenterology, Chyke A. Doubeni, MD, MPH, Chair of the Department of Family Medicine and Community Health at the Perelman School of Medicine and a PRC researcher, and Robert H. Fletcher, MD of Harvard Medical School, call for a reassessment of colorectal cancer screening guidelines.
“The accumulated evidence shows that the risk of a colorectal cancer diagnosis in patients associated with having a family history of the condition becomes progressively smaller with increasing age, as does the association between family history and death from colorectal cancer,” Doubeni said. “Current standards recommend aggressive screening until age 75 to 85, but now a growing body of evidence show that it is not necessary to continue to screen most older people with a family history that aggressively.”
In light of these findings, for patients over 55—particularly those 65 years and older—who have only one immediate family member with colorectal cancer, Doubeni advocates for screening as recommended for average risk individuals (colonoscopy every ten years or other recommended screening test such as fecal immunochemical test every year). Those with two or more first-degree relatives with the disease, he says, should continue to receive a colonoscopy more often until more evidence is available.